The Global Market for Insomnia: Trends, Forecasts, and Competitive Analysis to 2030 Featuring Vanda Pharma, Neurim, Eisai, Purdue Pharma, Merck, Pfizer, Astellas, Flynn Pharma, Takeda Pharma, SkyePharma
April 12, 2024 09:55 ET
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Insomnia Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The global...
Global Insomnia Market Report 2022 to 2028: Increasing Aging Population & Healthcare Costs Drives Growth
January 24, 2023 06:38 ET
|
Research and Markets
Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Global Insomnia Market Size, Share & Industry Trends Analysis Report by Distribution Channel, Therapy Type, Regional Outlook and Forecast,...
Global Insomnia Market Report to 2030 - Featuring Currax Pharmaceuticals, Eisai, Minerva Neurosciences and Pfizer Among Others
October 12, 2022 05:38 ET
|
Research and Markets
Dublin, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The "Insomnia Market By Therapy Type: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's...
The Insomnia Industry 2021-2026: Comprehensive Regional Insights and Competitor Analyses
October 01, 2021 09:38 ET
|
Research and Markets
Dublin, Oct. 01, 2021 (GLOBE NEWSWIRE) -- The "Global Insomnia Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. This report provides comprehensive...